A Prospective, Observational, Cohort Study to Assess the Efficacy and Safety of Prolonged-Release Fampridine in Cognition, Fatigue, Depression, and Quality of Life in Multiple Sclerosis Patients: The FAMILY Study

INTRODUCTION: The efficacy of prolonged-release fampridine (PR-FAM) may extend in multiple sclerosis (MS) beyond walking ability. The objective of this study was to evaluate the effect of PR-FAM treatment on cognition, fatigue, depression, and quality of life (QoL) in adult patients with MS in a rea...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitsikostas, Dimos D., Doskas, Triantafyllos, Gkatzonis, Stylianos, Fakas, Nikolaos, Maltezou, Maria, Papadopoulos, Dimitrios, Gourgioti, Rania, Mitsias, Panayiotis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932964/
https://www.ncbi.nlm.nih.gov/pubmed/33528792
http://dx.doi.org/10.1007/s12325-020-01606-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932964/
https://www.ncbi.nlm.nih.gov/pubmed/33528792
http://dx.doi.org/10.1007/s12325-020-01606-5

Ejemplares similares